Sarissa Biomedical Overview

  • Founded
  • 2002

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees
  • Latest Deal Type
  • M&A

Sarissa Biomedical General Information

Description

Developer of a hand-held point-of-care diagnostic device designed to identify people who are having a stroke. The company's technology is a point-of-care test that uses finger-prick blood samples which is then directed, monitored and controlled by software, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Acquirer
Zimmer & Peacock
Primary Office
  • Unit 4B, Vanguard Centre
  • Sir William Lyons Road, Warwick University Science Park
  • Coventry CV4 7EZ
  • England, United Kingdom
+44 024 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sarissa Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 28-May-2021 00.000 Completed Generating Revenue
14. Later Stage VC 20-May-2020 00.000 00.000 00.000 Completed Generating Revenue
13. Later Stage VC 08-Mar-2019 00000 00.00 00.000 Completed Generating Revenue
12. Grant 17-May-2018 00.000 00.000 Completed Generating Revenue
11. Later Stage VC 12-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
10. Later Stage VC 31-Mar-2017 00000 00.000 00.000 Completed Generating Revenue
9. Grant 04-Jul-2016 00000 00.000 Completed Generating Revenue
8. Grant 01-Mar-2016 00000 00.000 Completed Startup
7. Later Stage VC 22-Dec-2015 $238K $1.65M 00.000 Completed Startup
6. Grant 01-Oct-2014 $24.4K $1.41M Completed Startup
To view Sarissa Biomedical’s complete valuation and funding history, request access »

Sarissa Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
A Ordinary 128,138 $0.012348 $2.73 $2.73 1x $2.73 12.88%
Preference 84,779 $0.012348 $2.73 $2.73 1x $2.73 8.52%
To view Sarissa Biomedical’s complete cap table history, request access »

Sarissa Biomedical Patents

Sarissa Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201509973-D0 Methods and devices to detect stroke in a subject Ceased 09-Jun-2015 000000000
US-20180163245-A1 Methods and devices to detect stroke in a subject Granted 09-Jun-2015 000000000 0
US-10907189-B2 Methods and devices to detect stroke in a subject Active 09-Jun-2015 000000000 0
US-20180155754-A1 Methods and devices to detect the presence of a condition associated with atp depletion in a subject Granted 09-Jun-2015 000000000
US-10889846-B2 Methods and devices to detect the presence of a condition associated with atp depletion in a subject Active 09-Jun-2015 C12Q1/005 0
To view Sarissa Biomedical’s complete patent history, request access »

Sarissa Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sarissa Biomedical Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Advantage West Midlands Government 000 0000 000000 0
EarlyStage.nyc Fund Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »